Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Exact Sciences Appoints Industry Analyst To New BD Role

This article was originally published in Clinica

Executive Summary

Exact Sciences Corp., maker of the Cologuard, a colorectal cancer screening test, appointed Jeff Elliott VP, business development and strategy, effective June 20. In the new role, Elliott will oversee the identification and pursuit of strategic business opportunities to help drive Cologuard's success. Elliott previously served as a senior research analyst at Robert W. Baird & Co., monitoring diagnostics and life science tools companies. Previously, he worked in a supply chain role for Walgreen Co.and as a consultant at Cap Gemini Ernst & Young. Elliott will report directly to Kevin Conroy, chairman and CEO of Exact Sciences.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst